GB201319878D0 - Method, Array and use thereof - Google Patents

Method, Array and use thereof

Info

Publication number
GB201319878D0
GB201319878D0 GBGB1319878.3A GB201319878A GB201319878D0 GB 201319878 D0 GB201319878 D0 GB 201319878D0 GB 201319878 A GB201319878 A GB 201319878A GB 201319878 D0 GB201319878 D0 GB 201319878D0
Authority
GB
United Kingdom
Prior art keywords
array
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1319878.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunovia AB
Original Assignee
Immunovia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia AB filed Critical Immunovia AB
Priority to GBGB1319878.3A priority Critical patent/GB201319878D0/en
Publication of GB201319878D0 publication Critical patent/GB201319878D0/en
Priority to MX2016006125A priority patent/MX2016006125A/es
Priority to KR1020167015574A priority patent/KR102240473B1/ko
Priority to PCT/GB2014/053340 priority patent/WO2015067969A2/en
Priority to US15/035,953 priority patent/US20160252513A1/en
Priority to AU2014345484A priority patent/AU2014345484B2/en
Priority to ES14815406T priority patent/ES2704888T3/es
Priority to EP14815406.5A priority patent/EP3069143B1/en
Priority to JP2016552704A priority patent/JP6600637B2/ja
Priority to BR112016010510A priority patent/BR112016010510A2/pt
Priority to CA2930211A priority patent/CA2930211A1/en
Priority to CN201480071589.2A priority patent/CN105917230B/zh
Priority to US16/161,741 priority patent/US20190128891A1/en
Priority to US17/704,057 priority patent/US20220214344A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
GBGB1319878.3A 2013-11-11 2013-11-11 Method, Array and use thereof Ceased GB201319878D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1319878.3A GB201319878D0 (en) 2013-11-11 2013-11-11 Method, Array and use thereof
CN201480071589.2A CN105917230B (zh) 2013-11-11 2014-11-11 用于确定胰腺癌的方法、阵列和其用途
ES14815406T ES2704888T3 (es) 2013-11-11 2014-11-11 Método, matriz y uso de los mismos para determinar cáncer de páncreas
JP2016552704A JP6600637B2 (ja) 2013-11-11 2014-11-11 膵臓がんを決定するための方法、アレイおよびそれらの使用
PCT/GB2014/053340 WO2015067969A2 (en) 2013-11-11 2014-11-11 Method, array and use thereof
US15/035,953 US20160252513A1 (en) 2013-11-11 2014-11-11 Method, array and use thereof
AU2014345484A AU2014345484B2 (en) 2013-11-11 2014-11-11 Method, array and use thereof for determining pancreatic cancer
MX2016006125A MX2016006125A (es) 2013-11-11 2014-11-11 Procedimiento, matriz y uso de los mismos.
EP14815406.5A EP3069143B1 (en) 2013-11-11 2014-11-11 Method, array and use thereof for determining pancreatic cancer
KR1020167015574A KR102240473B1 (ko) 2013-11-11 2014-11-11 방법, 어레이 및 그의 용도
BR112016010510A BR112016010510A2 (pt) 2013-11-11 2014-11-11 método, arranjo e uso do mesmo
CA2930211A CA2930211A1 (en) 2013-11-11 2014-11-11 Method, array and use thereof
US16/161,741 US20190128891A1 (en) 2013-11-11 2018-10-16 Method, array and use thereof
US17/704,057 US20220214344A1 (en) 2013-11-11 2022-03-25 Method, array and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1319878.3A GB201319878D0 (en) 2013-11-11 2013-11-11 Method, Array and use thereof

Publications (1)

Publication Number Publication Date
GB201319878D0 true GB201319878D0 (en) 2013-12-25

Family

ID=49818441

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1319878.3A Ceased GB201319878D0 (en) 2013-11-11 2013-11-11 Method, Array and use thereof

Country Status (12)

Country Link
US (3) US20160252513A1 (enExample)
EP (1) EP3069143B1 (enExample)
JP (1) JP6600637B2 (enExample)
KR (1) KR102240473B1 (enExample)
CN (1) CN105917230B (enExample)
AU (1) AU2014345484B2 (enExample)
BR (1) BR112016010510A2 (enExample)
CA (1) CA2930211A1 (enExample)
ES (1) ES2704888T3 (enExample)
GB (1) GB201319878D0 (enExample)
MX (1) MX2016006125A (enExample)
WO (1) WO2015067969A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2490025A3 (en) 2007-03-27 2012-11-28 Immunovia AB Method, array and use thereof
GB201014837D0 (en) 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
CN105021825B (zh) * 2015-07-09 2016-08-17 陈勇 一种检测胰腺癌相关多肽dap44的elisa试剂盒
GB201516801D0 (en) 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
GB201609951D0 (en) * 2016-06-07 2016-07-20 Immunovia Ab Biomarkers signatures and uses thereof
GB201609950D0 (en) * 2016-06-07 2016-07-20 Immunovia Ab Biomarkers signatures and uses thereof
US20190317098A1 (en) * 2016-11-24 2019-10-17 Huvet Bio, Inc. Composition for diagnosis of diseases
GB201701572D0 (en) * 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
KR102536314B1 (ko) * 2018-05-23 2023-05-25 주식회사 휴벳바이오 질환의 진단용 조성물
US11487739B2 (en) * 2019-02-19 2022-11-01 Nasdaq, Inc. System and methods for data model detection and surveillance
CA3138991A1 (en) * 2019-05-02 2020-11-05 Ligandal, Inc. Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents
WO2020235943A1 (ko) * 2019-05-21 2020-11-26 (주)아큐레시스바이오 암의 진단용 조성물
GB202010970D0 (en) * 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
KR102226826B1 (ko) * 2020-08-06 2021-03-11 주식회사 휴벳바이오 버피 코트 시료에 사용하기 위한 췌장암 진단용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3169789D1 (en) 1980-05-02 1985-05-15 Edward P Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US6727066B2 (en) * 2000-07-28 2004-04-27 Incyte Corporation Genes expressed in treated human C3A liver cell cultures
CN1659287A (zh) * 2002-04-05 2005-08-24 美国政府健康及人类服务部 诊断肝癌转移或发病可能性及鉴定治疗靶点的方法
JP4679149B2 (ja) * 2002-09-30 2011-04-27 オンコセラピー・サイエンス株式会社 ヒト膵癌に関連する遺伝子およびポリペプチド
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
US7790867B2 (en) * 2002-12-05 2010-09-07 Rosetta Genomics Inc. Vaccinia virus-related nucleic acids and microRNA
EP1638510B1 (en) * 2003-07-01 2015-09-02 Immunomedics, Inc. Multivalent carriers of bi-specific antibodies
KR101282396B1 (ko) * 2004-05-28 2013-07-04 어젠시스 인코포레이티드 Ｐｓｃａ 단백질에 결합하는 암 진단용 항체
US8383357B2 (en) * 2005-03-16 2013-02-26 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
CA2604844A1 (en) * 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics, Inc. Cancer-related genes
JP2007051880A (ja) * 2005-08-15 2007-03-01 Tokyo Univ Of Science 膵臓癌の検出方法、膵臓癌の診断キット
EP1974058B1 (en) * 2006-01-11 2014-06-11 Genomic Health, Inc. Gene expression markers for colorectal cancer prognosis
EP2490025A3 (en) * 2007-03-27 2012-11-28 Immunovia AB Method, array and use thereof
JP2010532484A (ja) * 2007-06-29 2010-10-07 コレロジック システムズ，インコーポレイテッド 卵巣癌のための予測マーカー
US7951549B2 (en) * 2008-03-07 2011-05-31 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
GB0815846D0 (en) * 2008-09-01 2008-10-08 Immunovia Ab diagnosis, prognosis and imaging of disease
CA3024643C (en) * 2009-03-12 2021-08-03 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
US20120264634A1 (en) * 2009-09-29 2012-10-18 Protagen Aktiengesellschaft Marker Sequences for Pancreatic Cancer Diseases, Pancreatic Carcinoma and Use Thereof
MY185582A (en) * 2010-01-07 2021-05-24 Malaysian Palm Oil Board Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease
CN102279264A (zh) * 2010-06-09 2011-12-14 李彬 48种恶性肿瘤标志物抗体芯片的制备方法
US20120040858A1 (en) * 2010-08-13 2012-02-16 Morehouse School Of Medicine Biomarkers for stroke
GB201103726D0 (en) * 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
WO2012139628A1 (en) * 2011-04-11 2012-10-18 Lykera Biomed Sa Coding polypurine hairpins for the treatment of cancer

Also Published As

Publication number Publication date
EP3069143A2 (en) 2016-09-21
MX2016006125A (es) 2016-08-12
US20220214344A1 (en) 2022-07-07
AU2014345484A1 (en) 2016-06-30
CN105917230B (zh) 2020-06-16
CN105917230A (zh) 2016-08-31
US20190128891A1 (en) 2019-05-02
ES2704888T3 (es) 2019-03-20
WO2015067969A3 (en) 2015-08-06
AU2014345484B2 (en) 2020-08-27
BR112016010510A2 (pt) 2017-12-05
JP6600637B2 (ja) 2019-10-30
EP3069143B1 (en) 2018-10-10
JP2016537652A (ja) 2016-12-01
WO2015067969A2 (en) 2015-05-14
KR20160085327A (ko) 2016-07-15
KR102240473B1 (ko) 2021-04-15
US20160252513A1 (en) 2016-09-01
CA2930211A1 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
GB201319878D0 (en) Method, Array and use thereof
ZA201506216B (en) Phototherapeutic device, method and use
EP3040939A4 (en) MAKEUP SUPPORT DEVICE, MAKEUP SUPPORT PROCESS AND MAKEUP SUPPORT PROGRAM
EP3026891A4 (en) Imaging element, imaging method, and program
EP2962597A4 (en) MAKEUP ASSISTANCE DEVICE, MAKEUP ASSISTANCE PROCEDURE AND MAKEUP ASSISTANCE PROGRAM
EP3039991A4 (en) MAKE-UP ASSISTING DEVICE, MAKE-UP ASSISTING METHOD, AND MAKE-UP ASSIST PROGRAM
SG11201605015XA (en) Decoding device, method, and program
GB201306633D0 (en) Biaising circuitry and method thereof
SG11201605757SA (en) Substituted amino triazoles, and methods using same
SG11201509964UA (en) Retainer, method for producing same and use thereof
GB201516801D0 (en) Method, array and use thereof
IL227627A0 (en) Method and device for determining geographic location
EP3032307A4 (en) Imaging device, imaging method and program
EP2961478A4 (en) Phototherapeutic device, method and use
EP3040754A4 (en) Imaging device, method, and program
EP3001401A4 (en) Decoding device, decoding ability providing device, method thereof, and program
GB201305940D0 (en) Methods and arrays for use in the same
GB201305411D0 (en) System and method
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
PL3033532T3 (pl) Element łączący, zastosowanie i sposób
EP3041217A4 (en) Imaging device, method and program
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
EP2995945A4 (en) Purification device, and purification method
EP3089622A4 (en) Uni-directional rigidifier and method
PL2805901T3 (pl) Zgarniacz, urządzenie utrzymujące i zespół zgarniacza

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)